|
78
|
270
|
7vvuP |
Nua4 hat module bound to the nucleosome |
|
78
|
270
|
7vvzP |
Nua4 bound to the nucleosome |
|
2
|
10
|
7wgqB |
X-ray structure of human ppar gamma ligand binding domain-pemafibrate co-crystals obtained by co-crystallization |
|
2
|
11
|
7wgpB |
X-ray structure of human ppar gamma ligand binding domain-fenofibric acid co-crystals obtained by co-crystallization |
|
2
|
12
|
7wgoB |
X-ray structure of human ppar gamma ligand binding domain-bezafibrate co-rystals obtained by co-crystallization |
|
4
|
18
|
7rleB |
Crystal structure of ppar gamma in complex with creb-binding protein and agonist gw1929 |
|
41
|
114
|
7xi0A |
Crystal structure of cbp bromodomain liganded with ccs150 |
|
44
|
130
|
7xheA |
Crystal structure of cbp bromodomain liganded with ccs151 |
|
38
|
112
|
7xh6A |
Crystal structure of cbp bromodomain liganded with ccs1477 |
|
2
|
11
|
7xvyC |
Human estrogen receptor beta ligand-binding domain in complex with s-dpn |
|
2
|
11
|
7xwpC |
Human estrogen receptor beta ligand-binding domain in complex with (s)-3-(2-chloro-4-hydroxyphenyl)-2-(4-hydroxyphenyl)propanenitrile |
|
2
|
10
|
7xvzC |
Human estrogen receptor beta ligand-binding domain in complex with (r)-3-(2-chloro-4-hydroxyphenyl)-2-(4-hydroxyphenyl)propanenitrile |
|
2
|
11
|
7xwqC |
Human estrogen receptor beta ligand-binding domain in complex with (r)-2-(2-chloro-4-hydroxyphenyl)-3-(4-hydroxyphenyl)propanenitrile |
|
2
|
11
|
7xwrC |
Human estrogen receptor beta ligand-binding domain in complex with (s)-2-(2-chloro-4-hydroxyphenyl)-3-(4-hydroxyphenyl)propanenitrile |
|
166
|
558
|
7w9vK |
Cryo-em structure of nucleosome in complex with p300 acetyltransferase catalytic core (complex i) |
|
106
|
319
|
7chgA |
The structure of human pregnane x receptor in complex with an src-1 coactivator peptide and a limonoid compound |
|
49
|
134
|
7p4sA |
Bromodomain of human taf1 (2) with naphthyridinone compound |
|
31
|
97
|
7lvsB |
The cbp taz1 domain in complex with a cited2-hif-1-alpha fusion peptide |
|
99
|
252
|
7k6fA |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 in complex with mes (2-(n-morpholino)ethanesulfonic acid) |
|
48
|
123
|
7k42A |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to dioxane |
|
49
|
123
|
7k3oA |
Crystal structure of the unliganded second bromodomain (bd2) of human taf1 |
|
102
|
248
|
7k03A |
Crystal structure of the tandem bromodomain (bd1 and bd2) of human taf1 bound to atr kinase inhibitor azd6738 |
|
101
|
250
|
7k0dA |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 bound to mtorc1/2 inhibitor azd3147 |
|
39
|
113
|
7juoA |
Cbp bromodomain complexed with yf2-23 |
|
55
|
137
|
7jjgA |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to atr kinase inhibitor az20 |
|
52
|
130
|
7k1pA |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to bromosporine |
|
98
|
247
|
7k27A |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 bound to atr inhibitor az20 |
|
58
|
135
|
7jtcA |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to zs1-322 |
|
54
|
128
|
7k0uA |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to plk1 kinase inhibitor bi2536 |
|
55
|
137
|
7jspA |
Crystal structure of the second bromodomain (bd2) of human taf1 bound to atr kinase inhibitor azd6738 |
|
2
|
11
|
7cxhB |
The ligand-free structure of human ppargamma lbd q286e mutant in the presence of the src-1 coactivator peptide |
|
3
|
11
|
7cxfB |
The ligand-free structure of human ppargamma lbd c285y mutant in the presence of the src-1 coactivator peptide |
|
3
|
11
|
7cxkB |
The ligand-free structure of human ppargamma lbd r288h mutant in the presence of the src-1 coactivator peptide |
|
3
|
11
|
7cxiB |
The ligand-free structure of human ppargamma lbd f287y mutant in the presence of the src-1 coactivator peptide |
|
3
|
11
|
7cxjB |
The ligand-free structure of human ppargamma lbd r288c mutant in the presence of the src-1 coactivator peptide |
|
3
|
11
|
7cxlB |
The ligand-free structure of human ppargamma lbd s289c mutant in the presence of the src-1 coactivator peptide |
|
2
|
9
|
7bo6B |
Vdr complex with lca derivative |
|
2
|
11
|
7b39B |
Allene-based design of a noncalcemic vitamin d receptor agonist |
|
2
|
11
|
7aosC |
Crystal structure of the raralpha/rxralpha ligand binding domain heterodimer in complex with a fragment of src1 coactivator |
|
2
|
10
|
7oy4B |
Vdr complex of a side-chain hydroxylated derivatives of lithocholic acid |
|
2
|
10
|
7oxzB |
Vdr complex with a side-chain hydroxylated derivative of lithocholic acid |
|
98
|
248
|
7lb0A |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 bound to zs1-295 |
|
100
|
249
|
7lb1A |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 bound to zs1-585 |
|
99
|
247
|
7lb2A |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 bound to zs1-589 |
|
81
|
274
|
7d0rA |
Crystal structure of human hbo1-brpf2 in complex with crotonoyl-coenzyme a |
|
79
|
276
|
7d0pA |
Crystal structure of human hbo1-brpf2 in complex with propionyl-coenzyme a |
|
73
|
273
|
7d0oA |
Crystal structure of human hbo1-brpf2 in apo form |
|
80
|
274
|
7d0sA |
Crystal structure of human hbo1-brpf2 in complex with succinyl-coenzyme a |
|
85
|
276
|
7d0qA |
Crystal structure of human hbo1-brpf2 in complex with butyryl-coenzyme a |
|
101
|
256
|
7l6xA |
Crystal structure of the tandem bromodomain (bd1, bd2) of human taf1 bound to gne-371 |
